Financials

News Ideas Discussions Technicals Forecast Seasonals

2269 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to WUXI BIOLOGICS (CAYMAN) INC operating, investing, and financing activities

2269 free cash flow for H2 24 is 2.12 B HKD. For 2024, 2269 free cash flow was 1.65 B HKD and operating cash flow was 5.81 B HKD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—